Discontinued — last reported Q4 '21
Biogen Intangible Purchases decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $10.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Intangible Purchases shows an upward trend with a 13.9% CAGR.
Higher spending indicates a focus on R&D and future-proofing the product portfolio.
This metric tracks cash outflows for the acquisition or development of intangible assets, including software, patents, a...
Highly relevant for software and tech companies; often compared against R&D expense ratios.
purchases_of_intangibles| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.90M | $16.90M | $0.00 | $1.90M | $0.00 | $1.00M | $5.00M | $16.00M | $13.40M | $0.00 | $75.00M | $9.10M | $95.00M | $27.00M | $10.00M | $0.00 | $5.30M | $16.30M | $0.00 |
| QoQ Change | — | — | +789.5% | -100.0% | — | -100.0% | — | +400.0% | +220.0% | -16.3% | -100.0% | — | -87.9% | +944.0% | -71.6% | -63.0% | -100.0% | — | +207.5% | -100.0% |
| YoY Change | — | — | — | — | — | -100.0% | -94.1% | — | +742.1% | — | -100.0% | >999% | -43.1% | +609.0% | — | -86.7% | -100.0% | -94.4% | -39.6% | -100.0% |